Markets
BSE See NSE See 39,084.73
123.94 (0.32%)
collapse Related Readings collapse

IDBI Bank - Good Scope Ahead

| 12/30/2011 4:13 PM Friday

Given the current scenario, investors may be surprised to see a bank being recommended in our Low Priced Scrip column. PSU banks are facing headwinds like deterioration in asset quality, higher provisioning requirements and a slower growth rate. However, there are many compelling factors that have made us recommend IDBI Bank to our readers. A sustained pace of improvement in the concerned areas may lead to a rebound in the valuations of the bank. With the RBI taking a pause on the rate hike front, the interest rates seem to have peaked out. In addition to this, a favourable change in the loan mix with moderation in loan growth and sustained growth in savings deposits are likely to address issues such as asset-liability management and a low CASA ratio.

The increased branch network is also expected to help in the improvement of the bank’s CASA. The asset quality risk stemming from large restructured accounts may be receding. Last but not the least, on the valuations front, the scrip is trading at 0.65x of its book value. Considering these factors, we recommend investors to buy the scrip with a target price of Rs 105.

If we take a look at the performance of IDBI Bank for H1 FY12, the only good news was a 20 per cent growth in its advances. Many of the other factors were quite negative. For Q2 FY12, the NIM stood at two per cent, resulting in a contraction by 24 bps on a YoY basis and seven basis points on a QoQ basis. Further, as on September 30, 2011, the bank’s net NPAs increased by 0.38 bps to 1.57 per cent on a YoY basis, with a 32 bps  increase on a sequential basis.  

However, that is the past and the scenario is expected to improve going ahead. The first thing to watch out for is the improved deposit mix. For H1 FY12, the contribution of low-cost CASA deposits has gone up to 19.90 per cent as compared to 15.25 per cent in H1 FY11. The bank is planning to increase its number of branches to 1050 by the end of FY12, from the current number of 908, which will add value on the CASA front. This is also likely to result in an improvement in terms of the bank’s NIM. Even the management expects the NIM to be at 2.15 per cent for FY12.

On the NPAs side, FY11 saw some deterioration in IDBI’s asset quality on the back of higher slippages from the bank’s SME portfolio and restructured loans. Further, of its total exposure, that in the power sector is 14 per cent, which is very high and risky. However, the management has stated that the concerns pertaining to exposure to the power sector are of a medium to long-term nature, and the likelihood of the power sector advances turning into NPAs in the short term is very small. Another risk associated with the bank is that it has a high exposure of around Rs 719 crore to Kingfisher Airlines. The impact of this is expected to recede going forward.

The bank’s loan mix is undergoing a favourable change, with a decline in the proportion of term loans for a duration exceeding five years. This is likely to address the issue of asset-liability management, as IDBI has a tilt towards long duration infrastructure loans. Going ahead, the bank deliberately wants to reduce growth in advances to 16 per cent. This will help in improving the asset quality.

On the financial front, the net interest income (NII) of the bank increased by 15 per cent to Rs 2274 crore for H1 FY12, as compared to a similar period last year. Meanwhile, its PAT increased by 25 per cent to Rs 851 crore. With good financial performance and expected improvement in its NIM and asset class, we recommend a ‘buy’ on the counter. However, investors are advised not to jump in with all guns blazing, but to buy in a staggered manner, since some downside movement is expected

 

Find More Articles on: DSIJ Magazine, Low Priced Scrip, Stock Recommendations, Fundamental Picks, Product, Large Cap, Small Cap

news letter

More for the early bird.

Get the post-market reports and breakfast news right in your inbox. See latest »

DSIJ Mindshare

12345678910Last

Tiger Logistics topline to grow by 10%--buoyant over infra sector status to logistics sector

Tiger Logistics topline to grow by 10%--buoyant over infra sector status to logistics sector

Logistics sector will play a vital role in making the concept of ‘Make in India’ a success. This will be further aided by some of the recent steps taken by Government of India such as granting of infra sector status to logistics sector.

Best and worst Performing Sector Funds of Year 2017

Best and worst Performing Sector Funds of Year 2017

As the year-end has approached most of you are eager to know the mutual fund movers and shakers of the year 2017. Read on to find the performance of various sector dedicated funds.

Markets may start positive, but volatility likely due to F&O expiry

Markets may start positive, but volatility likely due to F&O expiry

The start of the F&O expiry day is likely to be in the green, but volatility may creep in with the progress of the session. The SGX Nifty suggests that the Nifty could open at 10,525 with gains of 32 points at the opening bell. 

Pidilite announces buyback of Rs 500 crore

Pidilite announces buyback of Rs 500 crore

The buyback offer comprises purchase of up to 50,00,000 equity shares. The buyback offer size comprises 0.975 per cent of the total paid-up equity capital of the company.

Bank Nifty drags markets to close in the red

Bank Nifty drags markets to close in the red

The late session fall in Bank Nifty changed the direction of the market, leading to a marginal fall in the benchmark indices. Bank Nifty yet again resisted at its multiple point downward sloping trendline level at 25733.

Six major underperforming MF schemes having higher expense ratios

Six major underperforming MF schemes having higher expense ratios

Mutual funds with a large size of assets under management (AUMs) are supposed to have lower expense ratios. However, there are schemes with large AUMs but having higher expense ratios and generating lower returns. 

Nifty Pharma supports market; Sun Pharma at bullish reversal

Nifty Pharma supports market; Sun Pharma at bullish reversal

Nifty Pharma index has come in as the healer in an otherwise sluggish market. Index has given a consolidation breakout at the 9420 level today and if the it sustains 9420, followed by 9628 on the upside, it has a long way to go.

Ten stocks close to their 52-week low

Ten stocks close to their 52-week low

Following stocks are close to their 52-week low as at 12.35 p.m. on December 27.

Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

The markets on December 27 opened gap down. BSE Sensex is trading at 34,068.15, up by 57.54 points and the Nifty is trading at 10,539.45, up by 7.95 points.

Five stocks with selling interest

Five stocks with selling interest

Overall volumes in futures & options currently stand at 62.75 lakh contracts with a turnover of Rs. 5,19,204.72 crore.